Jim Simons Bridge Bio Pharma, Inc. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $9.87 Million - $20.5 Million	584,146 New	584,146 $15.4 Million
Q1 2023 May 12, 2023	SELL	$7.17 - $18.55 $1.91 Million - $4.94 Million	-266,200 Reduced 25.85%	763,746 $12.7 Million
Q4 2022 Feb 13, 2023	SELL	$6.74 - $11.52 $2.27 Million - $3.88 Million	-336,800 Reduced 24.64%	1,029,946 $7.85 Million
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $7.57 Million - $11.8 Million	953,500 Added 230.73%	1,366,746 $13.6 Million
Q2 2022 Aug 12, 2022	BUY	$5.21 - $12.14 $2.15 Million - $5.02 Million	413,246 New	413,246 $3.75 Million
Q2 2021 Aug 13, 2021	SELL	$46.47 - $63.93 $5.51 Million - $7.58 Million	-118,546 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$55.47 - $72.35 $6.58 Million - $8.58 Million	118,546 New	118,546 $7.3 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.